GMR Solutions
Valuation each multiple against its own 5-year range
Vs. peers Medical Care Facilities
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| GMR Solutions (GMRS) | 560.75M | -7.41 | 0.71 | 0.00% |
| HCA Healthcare (HCA) | 97.66B | 15.13 | -14.70 | 0.67% |
| Tenet Healthcare (THC) | 21.24B | 10.20 | 4.56 | 0.00% |
| Encompass Health (EHC) | 12.17B | 20.09 | 4.68 | 0.62% |
| DaVita (DVA) | 11.44B | 14.78 | -14.95 | 0.00% |
| Fresenius Medical Care (FMS) | 11.21B | 11.33 | 0.80 | 4.06% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 42.1% below Morningstar's fair value estimate.
Fair value
GMR Solutions Inc earns a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 32% discount to our quantitative fair value estimate of $14.75 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The firm's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 147.7% ranks in the top 20% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.
The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 2.6, a core component of leverage, ranks in the bottom 30% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the company's weak financial health rating could portend bankruptcy risk if economic conditions weaken.
By Quantitative Equity Report
Quote time 2026-10-09 19:30:05 · For reference only, not investment advice and not tailored to your situation.
GMR Solutions discussion 0 comments